학술논문

Characteristics of clinical trials of influenza and respiratory syncytial virus registered in ClinicalTrials.gov between 2014 and 2021
Document Type
article
Source
Frontiers in Public Health, Vol 11 (2023)
Subject
influenza virus
respiratory syncytial virus (RSV)
infectious diseases
clinical trials registry
randomized clinical trial (RCT)
Public aspects of medicine
RA1-1270
Language
English
ISSN
2296-2565
Abstract
The randomized clinical trial (RCT) is the ideal and mandatory type of study to verify the effect and safety of a drug. Our aim is to examine the fundamental characteristics of interventional clinical trials on influenza and respiratory syncytial virus (RSV). This is a cross-sectional study of RCTs on influenza and RSV in humans between 2014 and 2021 registered in ClinicalTrials.gov. A total of 516 studies were identified: 94 for RSV, 423 for influenza, and 1 for both viruses. There were 51 RCTs of RSV vaccines (54.3%) and 344 (81.3%) for influenza virus vaccines (p